Consolidated Statements of Changes in Contingently Redeemable Convertible Preferred Stock and Stockholders’ Deficit - USD ($) shares in Thousands, $ in Thousands	Total	Contingently Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2021		10,826
Beginning balance at Dec. 31, 2021		$ 44,476
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of contingently redeemable preferred stock to common stock (in shares)		(10,826)
Conversion of contingently redeemable preferred stock to common stock		$ (44,476)
Ending balances (in shares) at Mar. 31, 2022		0
Ending balance at Mar. 31, 2022		$ 0
Beginning balance (in shares) at Dec. 31, 2021			271,576
Beginning balance at Dec. 31, 2021	$ 1,341,210		$ 27	$ 1,379,581	$ (27,432)	$ (10,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(466,204)				(466,204)
Other comprehensive income, net of $— income taxes	27,164					27,164
Stock-based compensation (in shares)			0
Stock-based compensation	20,573			20,573
Restricted stock awards issued, net of shares withheld for tax withholding obligations (in shares)			6,803
Restricted stock awards issued, net of shares withheld for tax withholding obligations	0		$ 1	(1)
Cashless exercise of warrants (in shares)			3,001
Cashless exercise of warrants	0
Conversion of contingently redeemable preferred stock to common stock (in shares)			10,826
Conversion of contingently redeemable preferred stock to common stock	44,476		$ 1	44,475
Issuances of common stock- Merger with XPDI (in shares)			30,778
Issuances of common stock - Merger with XPDI	163,459		$ 3	163,456
Issuances of common stock- vendor settlement (in shares)			1,580
Issuances of common stock - vendor settlement	12,674			12,674
Costs attributable to issuance of common stock and equity instruments - Merger with XPDI	(16,642)			(16,642)
Ending balance (in shares) at Mar. 31, 2022			324,564
Ending balance at Mar. 31, 2022	$ 1,126,710		$ 32	1,604,116	(493,636)	$ 16,198
Beginning balance (in shares) at Dec. 31, 2022	0
Beginning balance at Dec. 31, 2022	$ 0
Ending balances (in shares) at Mar. 31, 2023	0
Ending balance at Mar. 31, 2023	$ 0
Beginning balance (in shares) at Dec. 31, 2022	375,225		375,225
Beginning balance at Dec. 31, 2022	$ (409,346)		$ 36	1,764,368	(2,173,750)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(11,685)				(11,685)
Other comprehensive income, net of $— income taxes	0
Stock-based compensation	12,273			12,273
Restricted stock awards issued, net of shares withheld for tax withholding obligations (in shares)			2,616
Restricted stock awards issued, net of shares withheld for tax withholding obligations	$ 0		$ 0	0
Ending balance (in shares) at Mar. 31, 2023	377,841		377,841
Ending balance at Mar. 31, 2023	$ (408,758)		$ 36	$ 1,776,641	$ (2,185,435)